MedTrace Logo

Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.

NCT00151944 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2021-06-23

No results posted yet for this study

Summary

The purpose of this study is to test the long-term safety and tolerability of SPD476 in the maintenance of ulcerative colitis remission.

Conditions

  • Colitis, Ulcerative

Interventions

DRUG

SPD476 (mesalazine)

Sponsors & Collaborators

  • Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Takeda

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-26
Primary Completion
2006-03-13
Completion
2006-03-13

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00151944 on ClinicalTrials.gov